Efficacy and Tolerability of HAT1 Compared to Calcipotriol in Patients With Mild to Moderate Chronic Plaque Psoriasis

Conditions:   Psoriasis;   Psoriasis Vulgaris Interventions:   Drug: HAT1 topical solution;   Drug: Calcipotriol Sponsor:   Haus Bioceuticals Completed - verified February 2017

Source: ClinicalTrials.gov - February 27, 2017 Category: Research Source Type: clinical trials